Over
Even voorstellen
Als arts in opleiding ben ik werkzaam op de verschillende afdelingen binnen de KNO en de hoofd-hals oncologie. In mijn laatste jaar leg ik mij toe op de benigne en maligne hoofd-hals chirurgie en neusbijholtepathologie.
Werkervaring & opleidingen
2006 – 2013 Studie Geneeskunde, Rijkuniversiteit Groningen
2014 – 2015 ANIOS Heelkunde, IKAZIA Ziekenhuis, Rotterdam
2015 – 2015 ANIOS Intensive Care, Slootervaart Ziekenhuis, Amsterdam
2015 – 2019 ANIOS Hoofd-halschirurgie, Nederlands Kanker Instituut, Amsterdam
2015 – 2019 Arts onderzoeker hoofd-halschirurgie/radiotherapie, Nederlands Kanker Instituut, Amsterdam
2019 – heden AIOS KNO, ErasmusMC, Rotterdam
Publicaties
List of publications
2022 Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer. De Roest RH, van der Heijden M, Wesseling FWR, de Ruiter EJ, Heymans MW, Terhaard C, Vergeer MR, Buter J, Devriese LA, de Boer JP, Navran A, Hoeben A, Vens C, van den Brekel M, Brakenhoff RH, Leemans CR, Hoebers F. Radiother Oncol. 2022 Oct;175:112-121.
2020 Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma. Essers PBM, van der Heijden M, Vossen D, de Roest RH, Leemans CR, Brakenhoff RH, van den Brekel MWM, Bartelink H, Verheij M, Vens C. Int J Cancer. 2020 Sep 15;147(6):1732-1739
2020 Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy. van der Heijden M, Essers PBM, Verhagen CVM, Willems SM, Sanders J, de Roest RH, Vossen DM, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. Radiother Oncol. 2020 Jun;147:186-194.
2020 Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy. Keek S, Sanduleanu S, Wesseling F, de Roest R, van den Brekel M, van der Heijden M, Vens C, Giuseppina C, Licitra L, Scheckenbach K, Vergeer M, Leemans CR, Brakenhoff RH, Nauta I, Cavalieri S, Woodruff HC, Poli T, Leijenaar R, Hoebers F, Lambin P. PLoS One. 2020 May 22;15(5):e0232639.
2020 Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer. Bogowicz M, Jochems A, Deist TM, Tanadini-Lang S, Huang SH, Chan B, Waldron JN, Bratman S, O'Sullivan B, Riesterer O, Studer G, Unkelbach J, Barakat S, Brakenhoff RH, Nauta I, Gazzani SE, Calareso G, Scheckenbach K, Hoebers F, Wesseling FWR, Keek S, Sanduleanu S, Leijenaar RTH, Vergeer MR, Leemans CR, Terhaard CHJ, van den Brekel MWM, Hamming-Vrieze O, van der Heijden MA, Elhalawani HM, Fuller CD, Guckenberger M, Lambin P. Sci Rep. 2020 Mar 11;10(1):4542.
2020 Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation. van der Heijden M, Essers PBM, de Jong MC, de Roest RH, Sanduleanu S, Verhagen CVM, Hamming-Vrieze O, Hoebers F, Lambin P, Bartelink H, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. Front Oncol. 2020 Jan 10;9:1470.
2019 Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCC. Essers PBM, van der Heijden M, Verhagen CVM, Ploeg EM, de Roest RH, Leemans CR, Brakenhoff RH, van den Brekel MWM, Bartelink H, Verheij M, Vens C. Cancer Res. 2019 Nov 1;79(21):5597-5611.
2019 Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients. van der Heijden M, de Jong MC, Verhagen CVM, de Roest RH, Sanduleanu S, Hoebers F, Leemans CR, Brakenhoff RH, Vens C, Verheij M, van den Brekel MWM. Cancers (Basel). 2019 Apr 25;11(4):583.
2019 Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy. Vossen DM, Verhagen CVM, van der Heijden M, Essers PBM, Bartelink H, Verheij M, Wessels LFA, van den Brekel MWM, Vens C. Cancers (Basel). 2019 Mar 29;11(4):445.
2018 Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma. Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C. Oncotarget. 2018 Apr 6;9(26):18198-18213.
2016 Treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia. van der Heijden M, Dikkers FG, Halmos GB. Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1507-13
2015 The groningen laryngomalacia classification system--based on systematic review and dynamic airway changes. van der Heijden M, Dikkers FG, Halmos GB. Pediatr Pulmonol. 2015 Dec;50(12):1368-73.
2015 The influence of mechanical bowel preparation on long-term survival in patients surgically treated for colorectal cancer. van't Sant HP, Kamman A, Hop WC, van der Heijden M, Lange JF, Contant CM. Am J Surg. 2015 Jul;210(1):106-10.
2012 Serotype distribution and antimicrobial resistance of invasive pneumococcal disease strains in the Comunidad Valenciana, Spain, during the winter of 2009-2010: low PCV7 coverage and high levofloxacin resistance. Gant CM, Rosingh AW, López-Hontangas JL, van der Heijden M, González-Morán F, Bijlsma JJ, Canton E; RedMiva (Network of Microbiological Vigilance of Comunidad Valenciana). Antimicrob Agents Chemother. 2012 Sep;56(9):4988-9.
